Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amarendra Pegu

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cell Host & Microbe|June 15, 2023
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronavirusesCherrelle Dacon, Linghang Peng, Ting-Hui Lin, et al.
Science Translational Medicine|October 9, 2024
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivoJohn Misasi, Ronnie R Wei, Lingshu Wang, et al.
Cell Host & Microbe|November 8, 2022
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronavirusesCherrelle Dacon, Linghang Peng, Ting-Hui Lin, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.
Nature Communications|December 14, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.
Science (New York, N.Y.)|July 2, 2021
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
The New England Journal of Medicine|July 30, 2020
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman PrimatesKizzmekia S Corbett, Barbara Flynn, Kathryn E Foulds, et al.
Cell|October 29, 2024
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaquesHua Wang, Cheng Cheng, James L Dal Santo, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cell Host & Microbe|June 15, 2023
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronavirusesCherrelle Dacon, Linghang Peng, Ting-Hui Lin, et al.
Science Translational Medicine|October 9, 2024
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivoJohn Misasi, Ronnie R Wei, Lingshu Wang, et al.
Cell Host & Microbe|November 8, 2022
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronavirusesCherrelle Dacon, Linghang Peng, Ting-Hui Lin, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|April 5, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.
Nature Communications|December 14, 2022
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clonesNoemia S Lima, Maryam Musayev, Timothy S Johnston, et al.
Science (New York, N.Y.)|July 2, 2021
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
The New England Journal of Medicine|July 30, 2020
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman PrimatesKizzmekia S Corbett, Barbara Flynn, Kathryn E Foulds, et al.
Cell|October 29, 2024
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaquesHua Wang, Cheng Cheng, James L Dal Santo, et al.
Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.
Pageof 9